Table of Contents

	Personal Perspectives
		Harmonization of pharmaceutical regulation between CADREAC and the European Union*
	Vaccines and Biomedicines
		Gene transfer medicinal products*
		Gene transfer methods
		The regulatory situation
		Nomenclature of gene transfer medicinal products
	Safety Issues
		Interactions with grapefruit juice
		Miconazole oral gel: interaction with warfarin
		Fluoroquinolones and tendon disorders
		On-line reporting of adverse reactions
		Behaviour changes with fluoxetine, paroxetine and sertraline
		Hepatobiliary adverse reactions with the newer antidepressants?
		Convulsions with newer-generation antihistamines
	Regulatory and Safety Action
		Gene therapy retroviral vector trials “on hold”
		Contraceptives containing nonoxinol-9: new warning
		Fluoxetine approved for paediatric use
		Anorectic agents: reinstatement of marketing authorization
		Anakinra and combination therapy
		Estrogen and estrogen/progestin therapies: new safety information
		Diathermy and implanted leads
	International Nonproprietary Names (INN)
		Nomenclature for drug combinations*
		Naming of excipients: future challenges
	ATC/DDD Classification
		ATC/DDD Classification (final)
		ATC/DDD Classification (temporary)

WHO Drug Information Vol. 16, No. 4, 2002

WHO Drug Information

World Health Organization

WHO Drug Information
is now available at:
http://www.who.int/druginformation